Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Error in Results

Error in Results Correction In the Original Investigation titled “Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic,” published August 4, 2020, there were errors in the Figure and Results sections. The percentage of patients who were included in the COVID-19 period was 7.2%. The denominators given in the distribution of women with pancreatic cancer has been changed to 16 248 and 1546 to account for 21 patients who did not have gender information. In the Figure, an additional column was added to represent data on esophageal cancer, and the dates of the weeks in the periods examined were adjusted by 1 day. This article has been corrected. REFERENCE 1. Kaufman HW, Chen Z, Niles J, Fesko Y. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020;3(8):e2017267. doi:10. 1001/jamanetworkopen.2020.17267 Open Access. This is an open access article distributed under the terms of the CC-BY License. JAMA Network Open. 2020;3(9):e2020927. doi:10.1001/jamanetworkopen.2020.20927 (Reprinted) September 10, 2020 1/1 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Network Open American Medical Association

Error in Results

JAMA Network Open , Volume 3 (9) – Sep 10, 2020

Loading next page...
 
/lp/american-medical-association/error-in-results-bZMvC92kmF
Publisher
American Medical Association
Copyright
Copyright 2020. JAMA Network Open.
eISSN
2574-3805
DOI
10.1001/jamanetworkopen.2020.20927
Publisher site
See Article on Publisher Site

Abstract

Correction In the Original Investigation titled “Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic,” published August 4, 2020, there were errors in the Figure and Results sections. The percentage of patients who were included in the COVID-19 period was 7.2%. The denominators given in the distribution of women with pancreatic cancer has been changed to 16 248 and 1546 to account for 21 patients who did not have gender information. In the Figure, an additional column was added to represent data on esophageal cancer, and the dates of the weeks in the periods examined were adjusted by 1 day. This article has been corrected. REFERENCE 1. Kaufman HW, Chen Z, Niles J, Fesko Y. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020;3(8):e2017267. doi:10. 1001/jamanetworkopen.2020.17267 Open Access. This is an open access article distributed under the terms of the CC-BY License. JAMA Network Open. 2020;3(9):e2020927. doi:10.1001/jamanetworkopen.2020.20927 (Reprinted) September 10, 2020 1/1

Journal

JAMA Network OpenAmerican Medical Association

Published: Sep 10, 2020

References